Cyprus Healthcare Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Cyprus Healthcare Press.

Press releases published on June 16, 2026

Jun. 16, 2026

Avalo Therapeutics Expands Pipeline with AVTX-010, a Long-Acting Next-Generation Anti-IL-1β Antibody

Indeterminate GlobeNewswire

Jun. 16, 2026

HCW Biologics Announces Positive Results for Preliminary Human Data Readout for Phase 1 Clinical Trial Evaluating IL-2 Based Fusion Immunotherapeutic, HCW9302 Monotherapy, in Alopecia Areata

Indeterminate GlobeNewswire

Jun. 16, 2026

Pasithea Therapeutics Announces Amendments to Clinical Study Protocol for Phase 1/1B NF1 Clinical Trial

Indeterminate GlobeNewswire

Jun. 16, 2026

NovaBridge Biosciences Receives FDA Fast Track Designation for Givastomig in First-Line HER2-Negative Metastatic Gastric Cancer

Indeterminate GlobeNewswire

Jun. 16, 2026

NVision Named Winner in Fast Company’s 2026 World Changing Ideas Award

Indeterminate GlobeNewswire

Jun. 16, 2026

My Derma Dream MyoGlow Examined 2026 - Why Is the MyoGlow Arm Device Getting So Much Attention Across the United States?

Indeterminate GlobeNewswire

Jun. 16, 2026

Weston Family Foundation invests an additional $37 million to safeguard one of Canada’s most ecologically valuable and threatened ecosystems

Indeterminate GlobeNewswire

Jun. 16, 2026

King Faisal Specialist Hospital Showcases Applied AI Ecosystem in Radiology at HLTH Europe 2026

Indeterminate GlobeNewswire

Jun. 16, 2026

Das King Faisal Specialist Hospital präsentiert auf der HLTH Europe 2026 sein Ökosystem für angewandte KI in der Radiologie

Indeterminate GlobeNewswire

Jun. 16, 2026

À l’occasion du congrès HLTH Europe 2026, le King Faisal Specialist Hospital présente son écosystème d’IA appliquée en radiologie

Indeterminate GlobeNewswire

Jun. 16, 2026

Aplagon Announces EUR 5 Million Financing to Broaden Phase 2 Trials of its APAC Therapy in Thrombo-Inflammatory Diseases

Indeterminate GlobeNewswire

Jun. 16, 2026

Alvotech Announces Pricing of $152 Million Public Offering of Ordinary Shares and Concurrent Private Placement

Indeterminate GlobeNewswire